Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Male hypogonadism
Age: Adult
Dose: Intramuscular – 50-400 mg
Frequency: every 2-4 weeks
Note: Or an initial dose of 250 mg every 2-3 weeks followed by a maintenance dose every 3-6 weeks
Indication: Inoperable metastatic breast cancer
Age: Adult
Dose: Intramuscular – 200-400 mg
Frequency: every 2-4 weeks
Note: As enanthate

Child Dose

Clinical InformationAdministration Information
Indication: Hypogonadism
Age: less than 12 years
Dose: Safety and efficacy not established
Note: Safety and efficacy not established
Indication: Hypogonadism
Age: greater than 12 years
Dose: Intramuscular Injection – 50-400 mg
Frequency: every 2-4 weeks
Administration
  • Deep IM injection in gluteal muscle
  • Rotate injection sites
Side Effect

Drug Interaction

Drug NameRisk Factors
Ciclosporine, Antidiabetics (Metformin, Glibenclamide, Glimepiride, Sitagliptin, Pioglitazone, Rosiglitazone, Empagliflozin), Thyroxine, Anticoagulants (Warfarin, Heparin, Dabigatran, Rivaroxaban, Apixaban, Edoxaban)
Enhanced activities
Neuromuscular blockers
May cause resistance to effects

Disease Interaction

Disease NameRisk Factors
Hypercalcemia
Risk of calcium imbalance
Male Breast/Prostate Cancer
May stimulate cancer growth

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.